Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Endometrial Neoplasms × Brachytherapy × Clear all

Phase

Status

Completed 4 Recruiting 2 Active not recruiting 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 16 Prostatic Neoplasms 6 Neoplasms 2 Uveitis 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer 1 Sarcoma 1 Salivary Gland Neoplasms 1 Precancerous Conditions 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Obesity 1 Neurotoxicity Syndromes 1 Liver Neoplasms 1 Hyperthermia 1 Gliosarcoma 1 Glioblastoma 1 Fatigue 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1 Endometrial Clear Cell Adenocarcinoma 1 Deglutition Disorders 1 Choroid Neoplasms 1 Central Nervous System Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

Paclitaxel 6 Carboplatin 6 Radiotherapy 5 olaparib 4 Cisplatin 4 Surveys and Questionnaires 3 Surgical Procedures, Operative 3 Sentinel Lymph Node Biopsy 3 Metformin 3 pembrolizumab 2 lenvatinib 2 durvalumab 2 dostarlimab 2 anlotinib 2 Reverse Transcriptase Polymerase Chain Reaction 2 Progesterone 2 Magnetic Resonance Spectroscopy 2 Injections 2 Hematologic Tests 2 Genetic Testing 2 Docetaxel 2 Blood Specimen Collection 2 Amplified Fragment Length Polymorphism Analysis 2 vistusertib 1 serabelisib 1 pazopanib 1 palbociclib 1 onapristone 1 niraparib 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00411138 2023-10-11

PORTEC-3

Leiden University Medical Center

Phase 3 Unknown

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡